Based on extensive preclinical studies, MRANK-106 is differentiated from other WEE1 inhibitors in development by its: Dual targeting of WEE1 and YES1 kinases, providing synergistic anti-tumor effects ...
Heron Therapeutics' market cap has risen to ~$360 million, trading at ~$2.38, since my last Hold rating in November 2024.
Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...
At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...
A paper from 2018 in the American Journal of Cancer Research piqued his interest when he read that a little-known molecule ...
The college’s Visualizing Science competition finalists include the winning image of a Logistic Map’s Chaotic Portion by an ...
Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and demonstrated ...
Oxford Nanopore Technologies plc ( OTCPK:ONTTF) Q4 2024 Results Conference Call March 4, 2025 4:30 AM ET Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer ...
Saturation A molecule is saturated if every bond between carbon atoms is a single edge (think of a graph with only one edge between nodes). In our naming, if no edge in the parent chain is marked as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback